Search results for “Chronic pancreas inflammation” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 87 patents, we discovered top 22 key players by total patent application. CalciMedica, Inc. (US), Novartis AG, Arena Pharmaceuticals, Inc. are dominant in this area. They take 32.18% of the total patent filing.
CalciMedica, Inc. (US)
California, United States
Patent: 10
Novartis AG
Basel-Stadt, Switzerland
Patent: 9
Arena Pharmaceuticals, Inc.
California, United States
Patent: 9
GA Generic Assays GmbH
Berlin, Germany
Patent: 7
Takeda Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 6
Verona Pharma Plc
United Kingdom
Patent: 6
STARTUP
SciCann Therapeutics, Inc.
Ontario, Canada
Patent: 5
Cipla Ltd.
Maharashtra, India
Patent: 4
IFM Therapeutics
Massachusetts, United States
Patent: 4
Astellas Pharma, Inc.
Tokyo-to, Japan
Patent: 3
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 6 patents, we discovered top 2 start-ups by total patent application.
STARTUP
SciCann Therapeutics, Inc.
Ontario, Canada
Patent: 5
STARTUP
Ibrainbaby
Beijing Shi, China
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 82 patents applied in the last 5 years. We discover 23 most active companies in this area. The fast-growing Novartis AG, Arena Pharmaceuticals, Inc., SciCann Therapeutics, Inc. take 28.05% of patent filing during this period.
Novartis AG
Basel-Stadt, Switzerland
Patent: 9
Arena Pharmaceuticals, Inc.
California, United States
Patent: 9
STARTUP
SciCann Therapeutics, Inc.
Ontario, Canada
Patent: 5
IFM Therapeutics
Massachusetts, United States
Patent: 4
CalciMedica, Inc. (US)
California, United States
Patent: 4
Cipla Ltd.
Maharashtra, India
Patent: 3
Université Toulouse III - Paul Sabatier
France
Patent: 2
Jiangnan University
Jiangsu Sheng, China
Patent: 2
Société des Produits Nestlé SA
Vaud, Switzerland
Patent: 2
Cedars-Sinai Medical Center
California, United States
Patent: 2
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 82 patents in last 5 years, we discover 19 new entrants. Novartis AG, Arena Pharmaceuticals, Inc., SciCann Therapeutics, Inc. are the most active new entrants in this area.
Novartis AG
Basel-Stadt, Switzerland
Patent: 9
Arena Pharmaceuticals, Inc.
California, United States
Patent: 9
STARTUP
SciCann Therapeutics, Inc.
Ontario, Canada
Patent: 5
IFM Therapeutics
Massachusetts, United States
Patent: 4
Université Toulouse III - Paul Sabatier
France
Patent: 2
Jiangnan University
Jiangsu Sheng, China
Patent: 2
Société des Produits Nestlé SA
Vaud, Switzerland
Patent: 2
Cedars-Sinai Medical Center
California, United States
Patent: 2
Penland Foundation
United States
Patent: 2
STARTUP
Ibrainbaby
Beijing Shi, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 18 patents, we discovered top 4 universities and scientific research institutions by total patent application. Jiangnan University, Université Toulouse III - Paul Sabatier, Chiba University are dominant in this area. They take 33.33% of the total patent filing.
Jiangnan University
Jiangsu Sheng, China
Patent: 2
Université Toulouse III - Paul Sabatier
France
Patent: 2
Chiba University
Chiba-ken, Japan
Patent: 1
Kharkiv National Medical University
Ukraine
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: